TABLE 4.
Pharmacokinetics properties of 5g using different software.
| Properties | Predictions | |||
| SwissADME | pkCSM | PreADMET | vNN-ADMET | |
| GI absorption | High | 92.285% | 95.213% | - |
| BBB permeability | No | −0.013 | No | No |
| P-gp substrate | No | Yes | - | Yes |
| P-gp inhibitor | - | No | No | No |
| CYP1A2 inhibitor | Yes | No | - | No |
| CYP2C19 inhibitor | Yes | No | No | No |
| CYP2C9 inhibitor | No | No | No | No |
| CYP2D6 inhibitor | No | No | No | No |
| CYP3A4 inhibitor | Yes | Yes | No | No |